Tenet Healthcare - THC Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $94.73
  • Forecasted Upside: 2.08%
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 11 Buy Ratings
  • 1 Strong Buy Ratings
$92.80
▲ +0.42 (0.45%)

This chart shows the closing price for THC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tenet Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for THC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THC

Analyst Price Target is $94.73
▲ +2.08% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $94.73, with a high forecast of $109.00 and a low forecast of $81.00. The average price target represents a 2.08% upside from the last price of $92.80.

This chart shows the closing price for THC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 13 investment analysts is to buy stock in Tenet Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/1/2022
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/30/2022
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/28/2023
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/29/2023
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/27/2023
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/25/2023
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/24/2024
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/23/2024

Latest Recommendations

  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/15/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$98.00 ➝ $105.00Low
2/9/2024Truist FinancialBoost TargetBuy ➝ Buy$92.00 ➝ $105.00Low
2/9/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$97.00 ➝ $109.00Low
2/9/2024MizuhoBoost TargetBuy ➝ Buy$90.00 ➝ $100.00Low
2/9/2024Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$94.00 ➝ $104.00Low
11/20/2023Truist FinancialReiterated RatingBuy ➝ Buy$92.00Low
11/17/2023JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$91.00 ➝ $81.00Low
11/14/2023Jefferies Financial GroupLower TargetBuy ➝ Buy$95.00 ➝ $85.00Low
11/9/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$98.00 ➝ $85.00Low
11/2/2023UBS GroupLower TargetBuy ➝ Buy$104.00 ➝ $94.00Low
11/1/2023Raymond JamesLower TargetStrong-Buy ➝ Strong-Buy$95.00 ➝ $90.00Low
10/31/2023MizuhoLower TargetBuy ➝ Buy$94.00 ➝ $77.00Low
10/31/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$87.00 ➝ $72.00Low
10/20/2023Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$83.00 ➝ $71.00Low
9/14/2023Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$76.00 ➝ $94.00Low
8/14/2023The Goldman Sachs GroupBoost TargetBuy ➝ Buy$89.00 ➝ $98.00Low
8/2/2023Raymond JamesBoost TargetStrong-Buy ➝ Strong-Buy$85.00 ➝ $95.00Low
8/2/2023Credit Suisse GroupBoost TargetOutperform ➝ Outperform$92.00 ➝ $98.00Low
8/1/2023Royal Bank of CanadaBoost TargetOutperformer ➝ Outperform$84.00 ➝ $87.00Low
8/1/2023UBS GroupBoost TargetBuy ➝ Buy$95.00 ➝ $104.00Low
8/1/2023StephensBoost TargetEqual Weight ➝ Equal Weight$87.00 ➝ $89.00Low
8/1/2023CitigroupBoost TargetBuy ➝ Buy$83.00 ➝ $90.00Low
7/11/2023MizuhoBoost Target$81.00 ➝ $94.00Low
6/20/2023Truist FinancialBoost Target$84.00 ➝ $92.00Low
5/16/2023MizuhoBoost Target$78.00 ➝ $81.00Low
4/26/2023Deutsche Bank AktiengesellschaftBoost Target$65.00 ➝ $81.00Low
4/26/2023StephensBoost Target$64.00 ➝ $77.00Low
4/26/2023Truist FinancialBoost Target$74.00 ➝ $84.00Low
4/26/2023Raymond JamesBoost Target$72.00 ➝ $85.00Low
4/26/2023Royal Bank of CanadaBoost Target$73.00 ➝ $84.00Low
4/26/2023BarclaysBoost Target$70.00 ➝ $105.00Low
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$73.00Low
4/19/2023JPMorgan Chase & Co.Initiated CoverageOverweight$72.00Low
2/22/2023StephensBoost TargetEqual Weight$60.00 ➝ $64.00N/A
2/17/2023Wells Fargo & CompanyBoost TargetOverweight$59.00 ➝ $68.00Low
2/17/2023MizuhoBoost TargetBuy$60.00 ➝ $78.00Low
2/14/2023UBS GroupBoost TargetBuy$47.00 ➝ $78.00Low
2/14/2023BarclaysBoost TargetOverweight$67.00 ➝ $70.00Low
2/10/2023Deutsche Bank AktiengesellschaftBoost TargetBuy$48.00 ➝ $65.00Low
2/10/2023Truist FinancialBoost TargetBuy$60.00 ➝ $66.00Low
2/10/2023Royal Bank of CanadaBoost TargetOutperform$69.00 ➝ $73.00Low
2/10/2023MizuhoReiterated RatingBuy$60.00Low
2/10/2023StephensBoost TargetEqual Weight$57.00 ➝ $60.00Low
1/3/2023Wells Fargo & CompanyBoost TargetOverweight$48.00 ➝ $59.00Low
1/3/2023Truist FinancialBoost Target$55.00 ➝ $60.00Low
12/6/2022Loop CapitalBoost Target$40.00 ➝ $45.00Low
11/2/2022MizuhoLower TargetBuy$80.00 ➝ $60.00Low
11/1/2022The Goldman Sachs GroupLower TargetBuy$93.00 ➝ $80.00Low
10/27/2022Credit Suisse GroupLower Target$80.00Low
10/27/2022Raymond JamesLower TargetStrong-Buy$135.00 ➝ $80.00Low
10/25/2022CitigroupLower TargetBuy$99.00 ➝ $76.00Low
10/25/2022SVB LeerinkLower TargetOutperform$89.00 ➝ $55.00Low
10/24/2022StephensLower TargetEqual Weight$65.00 ➝ $45.00Low
10/24/2022Truist FinancialLower Target$80.00 ➝ $55.00Low
10/24/2022Deutsche Bank AktiengesellschaftLower TargetBuy$90.00 ➝ $48.00Low
10/24/2022Wells Fargo & CompanyLower TargetOverweight$82.00 ➝ $48.00Low
10/24/2022BarclaysLower TargetOverweight$104.00 ➝ $67.00Low
10/21/2022Bank of AmericaLower Target$79.00 ➝ $64.00Low
8/24/2022SVB LeerinkBoost TargetOutperform$88.00 ➝ $93.00Low
8/2/2022MizuhoBoost TargetBuy$63.00 ➝ $80.00Low
7/29/2022Wells Fargo & CompanyLower Target$90.00 ➝ $82.00Low
7/28/2022UBS GroupLower TargetBuy$113.00 ➝ $91.00Low
7/25/2022StephensBoost Target$73.00Low
7/25/2022Truist FinancialBoost TargetBuy$75.00 ➝ $80.00Low
7/25/2022SVB LeerinkBoost TargetOutperform$68.00 ➝ $88.00Low
7/25/2022CitigroupLower TargetBuy$110.00 ➝ $99.00Low
7/24/2022Bank of AmericaBoost Target$70.00 ➝ $75.00Low
7/19/2022Credit Suisse GroupSet Target$104.00Low
7/15/2022SVB LeerinkLower TargetOutperform$110.00 ➝ $68.00Low
7/12/2022The Goldman Sachs GroupLower TargetBuy$108.00 ➝ $93.00N/A
7/11/2022Raymond JamesLower TargetStrong-Buy$120.00 ➝ $110.00N/A
7/7/2022Deutsche Bank AktiengesellschaftLower TargetBuy$110.00 ➝ $90.00N/A
7/1/2022MizuhoLower TargetBuy$103.00 ➝ $63.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$80.00Low
4/25/2022Wells Fargo & CompanyLower TargetOverweight$100.00 ➝ $90.00High
4/22/2022SVB LeerinkBoost TargetOutperform$100.00 ➝ $110.00High
4/22/2022Royal Bank of CanadaBoost TargetOutperform$89.00 ➝ $104.00High
4/22/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$100.00 ➝ $110.00High
4/22/2022CitigroupBoost TargetBuy$96.00 ➝ $110.00High
4/22/2022BarclaysBoost TargetOverweight$99.00 ➝ $104.00High
4/14/2022SVB LeerinkReiterated RatingBuy$100.00N/A
4/7/2022Truist FinancialBoost Target$90.00 ➝ $100.00Low
3/28/2022Wells Fargo & CompanyInitiated CoverageOverweight$100.00Medium
3/7/2022Jefferies Financial GroupBoost TargetBuy$120.00 ➝ $125.00Low
3/3/2022MizuhoBoost TargetBuy$90.00 ➝ $103.00Medium
3/1/2022The Goldman Sachs GroupReiterated RatingBuy ➝ BuyHigh
2/10/2022UBS GroupUpgradeNeutral ➝ Buy$83.00 ➝ $111.00High
2/9/2022Credit Suisse GroupBoost TargetOutperform$109.00 ➝ $111.00High
2/9/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$80.00 ➝ $100.00High
2/9/2022SVB LeerinkUpgradeMarket Perform ➝ Outperform$88.00 ➝ $100.00High
2/9/2022BarclaysBoost TargetOverweight$87.00 ➝ $99.00High
2/9/2022Truist FinancialUpgradeHold ➝ Buy$90.00High
1/20/2022Raymond JamesUpgradeOutperform ➝ Strong-Buy$105.00 ➝ $120.00Medium
1/7/2022SVB LeerinkBoost TargetMarket Perform$78.00 ➝ $88.00Medium
1/5/2022Truist FinancialBoost Target$78.00 ➝ $90.00High
12/21/2021BarclaysBoost TargetOverweight$81.00 ➝ $87.00High
11/10/2021MizuhoBoost TargetBuy$75.00 ➝ $90.00Low
11/9/2021StephensBoost TargetEqual Weight$77.00 ➝ $92.00Low
10/25/2021CitigroupBoost TargetBuy$88.00 ➝ $91.00Low
10/22/2021SVB LeerinkLower TargetMarket Perform$80.00 ➝ $78.00Medium
10/22/2021Truist FinancialBoost TargetHold$72.00 ➝ $78.00Low
10/22/2021Credit Suisse GroupBoost TargetOutperform$88.00 ➝ $95.00Low
10/13/2021Truist FinancialLower TargetHold$78.00 ➝ $72.00Low
9/27/2021SVB LeerinkInitiated CoverageMarket Perform$80.00High
9/23/2021UBS GroupInitiated CoverageNeutral$83.00Medium
9/8/2021BarclaysBoost TargetOverweight$78.00 ➝ $79.00Low
8/12/2021BarclaysUpgradeEqual Weight ➝ Overweight$62.00 ➝ $77.00Medium
8/9/2021MizuhoBoost TargetBuy$70.00 ➝ $75.00Low
7/23/2021Credit Suisse GroupBoost TargetOutperform$71.00 ➝ $88.00Medium
7/23/2021CitigroupInitiated CoverageBuy$70.84Medium
7/23/2021Royal Bank of CanadaBoost TargetOutperform$78.00 ➝ $83.00Medium
7/23/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$69.00 ➝ $80.00Medium
7/9/2021Seaport Res PtnReiterated RatingBuyMedium
6/18/2021Jefferies Financial GroupReiterated RatingBuyHigh
5/5/2021MizuhoBoost TargetBuy$55.00 ➝ $70.00Low
5/3/2021The Goldman Sachs GroupInitiated CoverageBuyHigh
4/23/2021BarclaysBoost Target$55.00 ➝ $62.00High
4/22/2021Truist FinancialBoost Target$56.00 ➝ $60.00Medium
4/22/2021CitigroupBoost Target$58.00 ➝ $65.00High
4/22/2021Credit Suisse GroupBoost TargetOutperform$58.00 ➝ $71.00High
4/22/2021Royal Bank of CanadaBoost TargetOutperform$57.00 ➝ $66.00High
4/9/2021MizuhoBoost TargetBuy$48.00 ➝ $55.00Medium
2/11/2021CitigroupBoost Target$50.00 ➝ $58.00Low
2/11/2021Credit Suisse GroupBoost TargetOutperform$52.00 ➝ $58.00Low
1/21/2021UBS GroupBoost TargetPositive ➝ Buy$37.00 ➝ $60.00High
1/14/2021Raymond JamesBoost TargetOutperform$55.00 ➝ $60.00High
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$27.00 ➝ $60.00Low
1/5/2021Bank of AmericaUpgradeNeutral ➝ Buy$45.00 ➝ $50.00N/A
12/18/2020MizuhoBoost TargetBuy$32.00 ➝ $48.00Medium
12/15/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyMedium
12/11/2020Smith Barney CitigroupBoost Target$33.00 ➝ $50.00High
12/11/2020Credit Suisse GroupBoost TargetOutperform$39.00 ➝ $48.00Medium
12/11/2020BarclaysBoost TargetEqual Weight$28.00 ➝ $46.00High
11/11/2020Piper SandlerBoost TargetNeutral$31.00 ➝ $36.00High
11/9/2020MizuhoBoost TargetBuy$30.00 ➝ $32.00High
10/22/2020Raymond JamesBoost TargetOutperform$40.00 ➝ $43.00High
9/21/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$28.00 ➝ $20.00High
9/4/2020Royal Bank of CanadaBoost Target$30.00 ➝ $35.00Low
8/14/2020Truist FinancialBoost Target$21.00 ➝ $30.00Medium
8/10/2020UBS GroupBoost TargetBuy$30.00 ➝ $35.00Low
8/5/2020Deutsche Bank AktiengesellschaftBoost TargetHold$25.00 ➝ $28.00High
8/4/2020Credit Suisse GroupReiterated RatingBuyHigh
6/11/2020UBS GroupLower TargetBuy$32.00 ➝ $30.00High
5/29/2020MizuhoLower TargetBuy$32.00 ➝ $30.00High
5/21/2020SunTrust BanksBoost TargetHold$22.00 ➝ $25.00Medium
5/20/2020CitigroupLower TargetBuy$35.00 ➝ $27.00High
5/14/2020UBS GroupLower TargetBuy$49.00 ➝ $32.00High
5/11/2020BarclaysBoost TargetEqual Weight$19.00 ➝ $22.00Low
5/6/2020Credit Suisse GroupReiterated RatingBuy$33.00Low
5/6/2020Wells Fargo & CompanyLower TargetEqual Weight$40.00 ➝ $32.00Low
5/6/2020Deutsche Bank AktiengesellschaftLower TargetHold$31.00 ➝ $25.00High
4/13/2020SunTrust BanksBoost TargetHold$18.00 ➝ $22.00Low
4/13/2020Royal Bank of CanadaReiterated RatingBuy$26.00Medium
4/3/2020SunTrust BanksLower TargetHold$42.00 ➝ $18.00High
3/25/2020BarclaysReiterated RatingHold$19.00High
3/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$32.00 ➝ $39.00High
2/26/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$31.00 ➝ $32.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$20.00Low
12/20/2019JPMorgan Chase & Co.Boost TargetUnderweight$23.00 ➝ $31.00Medium
12/18/2019SunTrust BanksBoost TargetHold$31.00 ➝ $42.00Medium
12/9/2019UBS GroupUpgradeNeutral ➝ Buy$24.00 ➝ $53.00High
11/7/2019MizuhoReiterated RatingBuyLow
11/6/2019MizuhoBoost Target$30.00 ➝ $33.00Low
11/6/2019SunTrust BanksBoost TargetHold$24.00 ➝ $31.00High
11/6/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform$25.00 ➝ $36.00High
8/14/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$28.00 ➝ $28.00High
8/11/2019Royal Bank of CanadaReiterated RatingHold$26.00Medium
8/7/2019SunTrust BanksSet TargetHold$24.00Low
5/1/2019SunTrust BanksLower TargetHold$27.00High
4/17/2019BarclaysSet TargetHold$24.00Medium
2/27/2019Raymond JamesBoost Target$37.00 ➝ $47.00Medium
2/27/2019CitigroupBoost TargetBuy ➝ Buy$35.00 ➝ $37.00High
2/26/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$21.00 ➝ $30.00High
(Data available from 2/24/2019 forward)

News Sentiment Rating

0.93 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 11 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/29/2023
  • 12 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2023
  • 15 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/27/2023
  • 10 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/27/2023
  • 3 very positive mentions
  • 21 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/26/2023
  • 13 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/26/2023
  • 11 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/25/2024
  • 35 very positive mentions
  • 25 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/24/2024

Current Sentiment

  • 35 very positive mentions
  • 25 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Tenet Healthcare logo
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Further, the company offers end-to-end and focused-point business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $92.80
Low: $92.50
High: $94.16

50 Day Range

MA: $82.43
Low: $73.64
High: $92.80

52 Week Range

Now: $92.80
Low: $49.76
High: $94.16

Volume

835,575 shs

Average Volume

1,067,239 shs

Market Capitalization

$9.28 billion

P/E Ratio

16.25

Dividend Yield

N/A

Beta

2.1

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Barclays PLC, Cantor Fitzgerald, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Raymond James, Royal Bank of Canada, Stephens, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for THC.

What is the current price target for Tenet Healthcare?

15 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $94.73, suggesting a possible upside of 2.1%. Royal Bank of Canada has the highest price target set, predicting THC will reach $109.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $81.00 for Tenet Healthcare in the next year.
View the latest price targets for THC.

What is the current consensus analyst rating for Tenet Healthcare?

Tenet Healthcare currently has 1 hold rating, 11 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THC will outperform the market and that investors should add to their positions of Tenet Healthcare.
View the latest ratings for THC.

What other companies compete with Tenet Healthcare?

How do I contact Tenet Healthcare's investor relations team?

Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is (469) 893-2200 and its investor relations email address is [email protected]. The official website for Tenet Healthcare is www.tenethealth.com. Learn More about contacing Tenet Healthcare investor relations.